Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome

  • Emman Shubbar1Email author,
  • Anikó Kovács2,
  • Shahin Hajizadeh2,
  • Toshima Z Parris3,
  • Szilárd Nemes3,
  • Katrin Gunnarsdóttir4,
  • Zakaria Einbeigi3,
  • Per Karlsson3 and
  • Khalil Helou3
BMC Cancer201313:1

DOI: 10.1186/1471-2407-13-1

Received: 24 July 2012

Accepted: 17 December 2012

Published: 2 January 2013

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
24 Jul 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
29 Aug 2012 Reviewed Reviewer Report - Fernando Schmitt
2 Oct 2012 Reviewed Reviewer Report - Rebecca Lamb
24 Oct 2012 Author responded Author comments - Emman Shubbar
Resubmission - Version 3
24 Oct 2012 Submitted Manuscript version 3
Resubmission - Version 4
Submitted Manuscript version 4
7 Nov 2012 Reviewed Reviewer Report - Rebecca Lamb
13 Nov 2012 Reviewed Reviewer Report - Fernando Schmitt
19 Nov 2012 Author responded Author comments - Emman Shubbar
Resubmission - Version 5
19 Nov 2012 Submitted Manuscript version 5
Resubmission - Version 6
Submitted Manuscript version 6
30 Nov 2012 Author responded Author comments - Emman Shubbar
Resubmission - Version 7
30 Nov 2012 Submitted Manuscript version 7
Publishing
17 Dec 2012 Editorially accepted
2 Jan 2013 Article published 10.1186/1471-2407-13-1

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Sahlgrenska Cancer Center, Department of Clinical Genetics, Institute of Biomedicine, Sahlgrenska Academy at University of Gothenburg
(2)
Pathology section, Department of Pathology, Sahlgrenska University Hospital
(3)
Sahlgrenska Cancer Center, Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg
(4)
Regional Cancer Centre (West), Western Sweden Health Care Region, Sahlgrenska University Hospital

Advertisement